Maintaining the stability of biotherapeutics and their formulation buffers is crucial and surfactant analysis is a key component to monitoring these attributes. Agilent has innovative solutions which include an HPLC column specifically designed to characterize non-ionic surfactant degradants, quickly separating them from other degradants and the intact surfactant. By screening for markers of surfactant degradation, you can ensure your formulation buffer remains stable, ultimately saving you time and money in the long run.